PHRI: Bayer partners with Population Health Research Institute (PHRI) on major global research study on COVID-19 treatments

MISSISSAUGA, ON, April 21, 2020 /CNW/ - Today, the Population Health Research Institute (PHRI) and Bayer Inc. announced plans to immediately launch a major clinical research program aimed at identifying potential COVID-19 treatments. The two studies will evaluate the safety and efficacy of different combination therapies including Bayer's chloroquine and interferon beta-1b.